Chronic disease management: a qualitative study investigating the barriers, facilitators and incentives perceived by Swiss healthcare stakeholders.

Détails

Ressource 1Télécharger: BIB_E1E8EC71A150.P001.pdf (193.52 [Ko])
Etat: Public
Version: de l'auteur
ID Serval
serval:BIB_E1E8EC71A150
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Chronic disease management: a qualitative study investigating the barriers, facilitators and incentives perceived by Swiss healthcare stakeholders.
Périodique
BMC Health Services Research
Auteur(s)
Lauvergeon Stéphanie, Burnand Bernard, Peytremann-Bridevaux Isabelle
ISSN
1472-6963 (Electronic)
ISSN-L
1472-6963
Statut éditorial
Publié
Date de publication
2012
Peer-reviewed
Oui
Volume
12
Numéro
176
Pages
1-9
Langue
anglais
Notes
Publication types: Journal Article
Résumé
BACKGROUND: Chronic disease management has been implemented for some time in several countries to tackle the increasing burden of chronic diseases. While Switzerland faces the same challenge, such initiatives have only emerged recently in this country. The aim of this study is to assess their feasibility, in terms of barriers, facilitators and incentives to participation.
METHODS: To meet our aim, we used qualitative methods involving the collection of opinions of various healthcare stakeholders, by means of 5 focus groups and 33 individual interviews. All the data were recorded and transcribed verbatim. Thematic analysis was then performed and five levels were determined to categorize the data: political, financial, organisational/ structural, professionals and patients.
RESULTS: Our results show that, at each level, stakeholders share common opinions towards the feasibility of chronic disease management in Switzerland. They mainly mention barriers linked to the federalist political organization as well as to financing such programs. They also envision difficulties to motivate both patients and healthcare professionals to participate. Nevertheless, their favourable attitudes towards chronic disease management as well as the fact that they are convinced that Switzerland possesses all the resources (financial, structural and human) to develop such programs constitute important facilitators. The implementation of quality and financial incentives could also foster the participation of the actors.
CONCLUSIONS: Even if healthcare stakeholders do not have the same role and interest regarding chronic diseases, they express similar opinions on the development of chronic disease management in Switzerland. Their overall positive attitude shows that it could be further implemented if political, financial and organisational barriers are overcome and if incentives are found to face the scepticism and non-motivation of some stakeholders.
Pubmed
Web of science
Open Access
Oui
Création de la notice
06/12/2012 18:55
Dernière modification de la notice
20/08/2019 16:05
Données d'usage